Skip to content

Development and Efficacy of an ADHD-CBT Program of Individual Cognitive Behavioral Therapy for Attention Deficit/Hyperactivity Disorder in Adulthood

Development and Preliminary Efficacy of an ADHD-CBT Program of Individual Cognitive Behavioral Therapy for Attention Deficit/Hyperactivity Disorder in Adulthood

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1030220650
Enrollment
12
Registered
2023-02-22
Start date
2023-02-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit / Hyperactivity Disorder

Interventions

This ADHD-CBT program was developed based on Safren's manual on individual cognitive-behavioral therapy for ADHD in adulthood. It involves 12-16 in-person weekly sessions, consisting of an interview a

Sponsors

Kuga Hironori
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Currently meeting the diagnostic criteria for ADHD and being treated 2. Clinical severity of ADHD symptoms (as assessed by CAARS or CGI-S) 3. 20 to 65 years of age 4. History of being treated and followed for at least three months, completed medication adjustments, and are on stable doses during the study period 5. Willing to return for required follow-up visits throughout the study period

Exclusion criteria

Exclusion criteria: 1. The patient has been hospitalized within 30 days prior to the date of registration 2. The patient currently presents with psychotic disorders, substance use disorders, manic episodes, or neurocognitive disorders (as confirmed by SCID) 3. The patient possesses severe suicidal ideation 4. The patient is identified as having an intelligence quotient of 80 (as assessed by WAIS-IV) 5. The patient has other issues that interfere with the implementation of cognitive behavioral therapy 6. The patient has been or is currently under structured treatment

Design outcomes

Primary

MeasureTime frame
Feasibility measures (study completion rate, dropout rate, adverse events), Conners' Adult ADHD Rating Scales Japanese Version

Secondary

MeasureTime frame
QIDS-J EQ-5D SCID CGI-S AQ

Contacts

Public ContactNaoki Takamatsu

National Center of Neurology and Psychiatry

naokitakamatsu@ncnp.go.jp+81-42-341-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026